Y-Biologics Competitors and Similar CompaniesClear all

G1 Therapeutics's competitors and similar companies include Immunomedics, Alpine Immune Sciences and DotBio.

	G1 Therapeutics G1 Therapeutics is a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of patients with cancer.	Immunomedics Immunomedics is a developer of monoclonal antibody-based products for the targeted treatment of cancer.	Alpine Immune Sciences Alpine Immune Sciences is a biotechnology company that develops protein-based immunotherapies.	DotBio DotBio is a biopharmaceutical company specializing in domain antibody therapies.
Founding Date	Founding Date 2008	Founding Date 1982	Founding Date 2015	Founding Date 2018
Type	Type Public	Type Subsidiary	Type Subsidiary	Type Private
Tags	Tags Healthcare biotech oncology pharma	Tags Healthcare biotech oncology pharma	Tags Healthcare biotech oncology pharma	Tags Healthcare biotech oncology pharma
Locations	Locations Durham, US HQ	Locations Morris Plains, US HQ	Locations Seattle, US HQ	Locations Singapore, SG HQ
Employees	Employees 17015% increase	Employees 8914% decrease	Employees 484% decrease	Employees 195% decrease
Financial
Revenue (est.)	Revenue (est.) $82.5m (FY, 2023)	Revenue (est.) $295k (FY, 2019)	Revenue (est.) $58.9m (FY, 2023)	Revenue (est.) N/A
Cost of goods	Cost of goods $7.2m (FY, 2023)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit $75.3m (FY, 2023)	Gross profit $295k (FY, 2019)	Gross profit N/A	Gross profit N/A
Net income	Net income ($48m) (FY, 2023)	Net income ($357.3m) (FY, 2019)	Net income ($32.2m) (FY, 2023)	Net income N/A
Operating ⚠
Patents (US)	Patents (US) 40 (FY, 2020)	Patents (US) 405 (Sep, 2022)	Patents (US) N/A	Patents (US) N/A
Funding
Total funding raised	Total funding raised $ 289.6m	Total funding raised $ 30m	Total funding raised $ 49.3m	Total funding raised $ 2.5m